Edition:
United Kingdom

VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

1.59USD
23 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.59
Open
$1.56
Day's High
$1.62
Day's Low
$1.56
Volume
12,066
Avg. Vol
66,448
52-wk High
$2.43
52-wk Low
$0.83

Chart for

About

VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system (CNS). Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II... (more)

Overall

Beta: -0.57
Market Cap(Mil.): $17.09
Shares Outstanding(Mil.): 10.75
Dividend: --
Yield (%): --

Financials

  VTGN.OQ Industry Sector
P/E (TTM): -- 30.49 33.71
EPS (TTM): -1.36 -- --
ROI: -245.77 14.98 14.48
ROE: -415.24 16.30 15.99

Earnings vs. Estimates